Reactivation of hepatitis B virus infection in patients with rheumatoid arthritis receiving tofacitinib: a real-world study

Ann Rheum Dis. 2018 May;77(5):780-782. doi: 10.1136/annrheumdis-2017-211322. Epub 2017 Jun 29.

Yi-Ming Chen^{1

2

3

4}, Wen-Nan Huang^{1

2}, Yi-Da Wu¹, Ching-Tsai Lin¹, Yi-Hsing Chen^{1

2}, Der-Yuan Chen^{1

2

3

4

5}, Tsu-Yi Hsieh^{1

6}

¹ Division of Allergy, Immunology and Rheumatology, Taichung Veterans General Hospital, Taichung, Taiwan.
² Faculty of Medicine, National Yang-Ming University, Taipei, Taiwan.
³ Institute of Biomedical Science, National Chung Hsing University, Taichung, Taiwan.
⁴ Rong Hsing Research Center for Translational Medicine, National Chung Hsing University, Taichung, Taiwan.
⁵ Institute of Microbiology and Immunology, Chung Shan Medical University, Taichung, Taiwan.
⁶ Ph D Program of Business, College of Business, Feng Chia University, Taichung, Taiwan.

No abstract available

Keywords: Infections; dmards (synthetic); rheumatoid arthritis; treatment.

Publication types